Lipella Pharmaceuticals Inc.
LIPO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,856 | $3 | $4 | $2 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $224 | $1 | $1 | $0 |
| Total Curr. Assets | $2,079 | $3 | $5 | $3 |
| Property Plant & Equip (Net) | $263 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $8 | $0 | $0 | $0 |
| Total NC Assets | $271 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,350 | $4 | $5 | $3 |
| Liabilities | – | – | – | – |
| Payables | $463 | $1 | $0 | $0 |
| Short-Term Debt | $44 | $43 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $135 | -$43 | $0 | $0 |
| Total Curr. Liab. | $642 | $1 | $1 | $1 |
| LT Debt | $220 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $220 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $862 | $1 | $1 | $1 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$19,228 | -$18 | -$17 | -$15 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $20,715 | $21 | $21 | $17 |
| Total Equity | $1,488 | $3 | $4 | $2 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,350 | $4 | $5 | $3 |
| Net Debt | -$1,592 | $40 | -$4 | -$2 |